Baseline characteristics and liver blood tests on admission for 310 COVID-19 patients
| Baseline characteristics* | Patients with COVID-19 (N=310) |
| Age, median (years) | 69 (range 21–95) |
| Male gender, % (n) | 61 (188/310) |
| Ethnicity, % (n) | |
| Caucasian | 96.5 (299/310) |
| Black | 1.6 (5/310) |
| Romany | 1.9 (6/310) |
| BMI (kg/m2) | 26 (15–55) |
| CRP (mg/L) | 155 (1.6–510) |
| MULBSTA score, median | 9 (range 2–19) |
| Death, % (n) | 26.8 (83/310) |
| Liver blood tests on admission, % (n) | |
| Bilirubin >20 μmol/L (range 0–21 μmol/L) | 5 (18/310) |
| ALT >40 IU/L (range 0–41 IU/L) | 20 (62/310) |
| AST >40 IU/L (range 0–40 IU/L) | 28 (87/310) |
| Alkaline phosphatase >130 IU/L (range 40–130 IU/L) | 17 (54/310) |
| GGT >40 IU/L (range 0–59 IU/L) | 48 (150/310) |
| Albumin <35 g/L (range 35–52 g/L) | 23 (71/310) |
*Mean (±SD) unless stated.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CRP, C reactive protein; GGT, gamma-glutamyl transferase.